BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hu X, Chen W. Role of epithelial-mesenchymal transition in chemoresistance in pancreatic ductal adenocarcinoma. World J Clin Cases 2021; 9(19): 4998-5006 [PMID: 34307550 DOI: 10.12998/wjcc.v9.i19.4998]
URL: https://www.wjgnet.com/2307-8960/full/v9/i19/4998.htm
Number Citing Articles
1
Erika Stefàno, Gianluca Rovito, Luca G. Cossa, Federica De Castro, Viviana Vergaro, Asjad Ali, Giulia My, Danilo Migoni, Antonella Muscella, Santo Marsigliante, Michele Benedetti, Francesco Paolo Fanizzi, Massimiliano F. Peana. Novel Pt (II) Complexes With Anticancer Activity Against Pancreatic Ductal Adenocarcinoma CellsBioinorganic Chemistry and Applications 2024; 2024(1) doi: 10.1155/bca/5588491
2
Chaithanya Ganji, Batoul Farran. Current clinical trials for epigenetic targets and therapeutic inhibitors for pancreatic cancer therapyDrug Discovery Today 2022; 27(5): 1404 doi: 10.1016/j.drudis.2021.12.013
3
Ziad Chebaro, Rola Abdallah, Adnan Badran, Kamar Hamade, Akram Hijazi, Marc Maresca, Joelle Edward Mesmar, Elias Baydoun. Study of the antioxidant and anti-pancreatic cancer activities of Anchusa strigosa aqueous extracts obtained by maceration and ultrasonic extraction techniquesFrontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1201969
4
Antonella Farina, Sara Tartaglione, Adele Preziosi, Patrizia Mancini, Antonio Angeloni, Emanuela Anastasi. PANC-1 Cell Line as an Experimental Model for Characterizing PIVKA-II Production, Distribution, and Molecular Mechanisms Leading to Protein Release in PDACInternational Journal of Molecular Sciences 2024; 25(6): 3498 doi: 10.3390/ijms25063498
5
Praveen Bhoopathi, Padmanabhan Mannangatti, Swadesh K. Das, Paul B. Fisher, Luni Emdad. Pancreatic Cancer: Basic Mechanisms and TherapiesAdvances in Cancer Research 2023; 159: 285 doi: 10.1016/bs.acr.2023.02.010
6
Aiste Gulla, Urte Andriusaityte, Gabrielius Zdanys, Elena Babonaite, Kestutis Strupas, Helena Kelly. The Impact of Epithelial–Mesenchymal Transition and Metformin on Pancreatic Cancer Chemoresistance: A Pathway towards Individualized TherapyMedicina 2022; 58(4): 467 doi: 10.3390/medicina58040467
7
Natalia Kluz, Leszek Kraj, Paulina Chmiel, Adam M. Przybyłkowski, Lucjan Wyrwicz, Rafał Stec, Łukasz Szymański. Correlation Between Antihypertensive Drugs and Survival Among Patients with Pancreatic Ductal AdenocarcinomaCancers 2024; 16(23): 3945 doi: 10.3390/cancers16233945
8
Min-Woo Nam, Hong Kyu Lee, Cho-Won Kim, Youngdong Choi, Dohee Ahn, Ryeo-Eun Go, Kyung-Chul Choi. Effects of CCN6 overexpression on the cell motility and activation of p38/bone morphogenetic protein signaling pathways in pancreatic cancer cellsBiomedicine & Pharmacotherapy 2023; 163: 114780 doi: 10.1016/j.biopha.2023.114780
9
Umbhorn Ungkulpasvich, Hideyuki Hatakeyama, Takaaki Hirotsu, Eric di Luccio. Pancreatic Cancer and Detection MethodsBiomedicines 2023; 11(9): 2557 doi: 10.3390/biomedicines11092557
10
Mona Tangsiri, Ali Hheidari, Mahsa Liaghat, Mahtab Razlansari, Narges Ebrahimi, Abdullatif Akbari, Seyed Mostafa Noorbakhsh Varnosfaderani, Fahimeh Maleki-Sheikhabadi, Ali Norouzi, Maryam Bakhtiyari, Hamidreza Zalpoor, Mohsen Nabi-Afjadi, Abbas Rahdar. Promising applications of nanotechnology in inhibiting chemo-resistance in solid tumors by targeting epithelial-mesenchymal transition (EMT)Biomedicine & Pharmacotherapy 2024; 170: 115973 doi: 10.1016/j.biopha.2023.115973
11
Antonella Farina, Valentina Viggiani, Francesca Cortese, Marta Moretti, Sara Tartaglione, Antonio Angeloni, Emanuela Anastasi. Combined PIVKA II and Vimentin-Guided EMT Tracking in Pancreatic Adenocarcinoma Combined Biomarker-Guided EMT Tracking in PDACCancers 2024; 16(13): 2362 doi: 10.3390/cancers16132362